January 16, 2018 / 1:39 PM / 3 months ago

BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.

Jan 16 (Reuters) - Sun Pharmaceutical Industries Ltd :

* SAYS CO’S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC

* ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US

* COMPANIES TO GRANT CO’S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES

* ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED. Source text - bit.ly/2Dl8eOU Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below